Neuphoria Therapeutics Inc
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Neuphoria Therapeutics Inc
Neuphoria Therapeutics Inc is a clinical-stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. The company is advancing its drug candidate, BNC 210, an oral, proprietary, selective negative allosteric modulator of the Alpha7 nicotinic acetylcholine receptor, for the acute treatment of social anxiety disorder and for chronic treatment of post-traumatic stress disorder. The Company operates through a single operating and reportable segment focused on the discovery and development of allosteric ion channel modulators.
/ 
Frequently asked questions
To buy Neuphoria Therapeutics Inc stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Neuphoria Therapeutics Inc by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Neuphoria Therapeutics Inc is NEUP:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Neuphoria Therapeutics Inc has its primary listing on NASDAQ. You can trade Neuphoria Therapeutics Inc with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Neuphoria Therapeutics Inc is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Neuphoria Therapeutics Inc as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Neuphoria Therapeutics Inc.